SCHEMBL1629564

SCHEMBL1629564

COc1cc(OC)c(-c2ccnn2-c2ccccc2Cl)cc1I

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.44
KCNN4 O15554 1/20 0.41
NR3C2 P08235 2/20 0.39
MAPT P10636 3/20 0.39
MAPK14 Q16539 2/20 0.39
FLT3 P36888 1/20 0.37
MAPK11 Q15759 1/20 0.37
PDE10A Q9Y233 3/20 0.35
P2RX7 Q99572 2/20 0.34
MAPK1 P28482 1/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ATM Q13315 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1631623 0.91 P2RX7 (0.42) HSP90AA1KCNN4NR3C2MAPTP2RX7
SCHEMBL1219068 0.86 HSP90AA1 (0.45) HSP90AA1NR3C2MAPTMAPK14FLT3
SCHEMBL1631531 0.85 HSP90AA1 (0.62) HSP90AA1KCNN4NR3C2MAPTMAPK14
SCHEMBL1629896 0.85 KCNN4 (0.44) HSP90AA1KCNN4NR3C2MAPTMAPK14
SCHEMBL1631575 0.85 HSP90AA1 (0.40) HSP90AA1NR3C2MAPTKDM5AKDM4C
SCHEMBL1630525 0.84 HSP90AA1 (0.44) HSP90AA1NR3C2PDE10AKDM5AKDM4C
SCHEMBL1630297 0.82 HSP90AA1 (0.41) HSP90AA1KCNN4NR3C2MAPTMAPK14
SCHEMBL1629555 0.82 PDE10A (0.48) HSP90AA1MAPTPDE10AMAPK1ALDH1A1
SCHEMBL1215371 0.81 MAPT (0.47) HSP90AA1KCNN4NR3C2MAPTMAPK14
SCHEMBL1219165 0.81 HSP90AA1 (0.40) HSP90AA1KCNN4NR3C2MAPTMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885KCNN4 4736/4885NR3C2 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.